Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progression

Quercetin is a flavonoid present in many vegetables, fruits, and beverages. Due to its anti‐oxidant, anti‐tumor, and anti‐inflammatory activity, quercetin has been studied extensively as a chemoprevention agent in several cancer models. Since most of these studies used higher doses of quercetin than clinically achievable, we focused on the effectiveness of physiologically relevant doses of quercetin. A low dose of quercetin exerted cancer cell‐specific inhibition of proliferation and this inhibition resulted from cell cycle arrest at the G1 phase. Quercetin induced p21 CDK inhibitor with a concomitant decrease of phosphorylation of pRb, which inhibits the G1/S cell cycle progression by trapping E2F1. A low dose of quercetin induced mild DNA damage and Chk2 activation, which is the main regulator of p21 expression by quercetin. In addition, quercetin down‐regulated the cyclin B1 and CDK1, essential components of G2/M cell cycle progression. Inhibition of the recruitment of key transcription factor NF‐Y to cyclin B1 gene promoter by quercetin led to transcriptional inhibition. This study proved that the chemo‐preventive efficacy of a physiologically relevant dose of quercetin can be achievable through the inhibition of cell cycle progression. J. Cell. Biochem. 106: 73–82, 2009. © 2008 Wiley‐Liss, Inc.

[1]  A. Menssen,et al.  Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Daiya Takai,et al.  The CpG Island Searcher: A new WWW resource , 2003, Silico Biol..

[3]  Z. Y. Wang,et al.  Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells. , 1993, Cancer letters.

[4]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[5]  M. Molinari.  Cell cycle checkpoints and their inactivation in human cancer , 2000, Cell proliferation.

[6]  A. Izzo,et al.  Flavonoids: old and new aspects of a class of natural therapeutic drugs. , 1999, Life sciences.

[7]  Chee Pang Ng,et al.  Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. , 2004, Oncology reports.

[8]  T. Hammond,et al.  Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. , 1998, Cancer research.

[9]  J. Kühnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976, World review of nutrition and dietetics.

[10]  A. Holmgren,et al.  Purification from placenta, amino acid sequence, structure comparisons and cDNA cloning of human glutaredoxin. , 1995, European journal of biochemistry.

[11]  K A Schafer,et al.  The Cell Cycle: A Review , 1998, Veterinary pathology.

[12]  J. Terao,et al.  Quercetin metabolites inhibit copper ion‐induced lipid peroxidation in rat plasma 1 , 1998, FEBS letters.

[13]  G. Block,et al.  Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. , 1992, Nutrition and cancer.

[14]  M. Kastan,et al.  The many substrates and functions of ATM , 2000, Nature Reviews Molecular Cell Biology.

[15]  K. Engeland,et al.  Cell cycle‐dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements , 2007, The FEBS journal.

[16]  L. Oberley,et al.  Role of superoxide dismutase in cancer: a review. , 1979, Cancer research.

[17]  R. Gugler,et al.  Disposition of quercetin in man after single oral and intravenous doses , 1975, European Journal of Clinical Pharmacology.

[18]  O. Dangles,et al.  Inhibition of the metmyoglobin-induced peroxidation of linoleic acid by dietary antioxidants: Action in the aqueous vs. lipid phase , 2005, Free radical research.

[19]  T. Hsia,et al.  INHIBITION OF LUNG CANCER CELL GROWTH BY QUERCETIN GLUCURONIDES VIA G2/M ARREST AND INDUCTION OF APOPTOSIS , 2006, Drug Metabolism and Disposition.

[20]  M. Campo,et al.  Quercetin elevates p27Kip1 and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1 , 2003, Oncogene.

[21]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[22]  D. Lee,et al.  Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. , 2008, Biochemical pharmacology.

[23]  Tae-Jin Lee,et al.  Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. , 2006, Cancer letters.

[24]  A. Holmgren,et al.  Thioredoxin and glutaredoxin systems. , 2019, The Journal of biological chemistry.

[25]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[26]  S. Elledge,et al.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Segura-Aguilar,et al.  Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. , 1999, Free radical biology & medicine.

[28]  J. Vialard,et al.  p53-Independent Regulation of p21Waf1/Cip1 Expression and Senescence by Chk2 , 2005, Molecular Cancer Research.

[29]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.

[30]  M. Suntharalingam,et al.  Role of Glutaredoxin in Metabolic Oxidative Stress , 2002, The Journal of Biological Chemistry.

[31]  H. Daniel,et al.  Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. , 2000, Cancer research.

[32]  J. Rowley,et al.  Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Blasina,et al.  Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1 , 2000, Nature Cell Biology.

[34]  K. Turksen,et al.  Isolation and characterization , 2006 .

[35]  W. Bors,et al.  Flavonoids as antioxidants: determination of radical-scavenging efficiencies. , 1990, Methods in enzymology.

[36]  S. J. Lee,et al.  Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. , 2001, International journal of oncology.

[37]  W. Bors,et al.  Flavonoid antioxidants: rate constants for reactions with oxygen radicals. , 1994, Methods in enzymology.

[38]  Hui Liu,et al.  Changes in mitochondrial membrane potential and reactive oxygen species during wogonin‐induced cell death in human hepatoma cells , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[39]  M. Fritsche,et al.  Flavonoids activate wild-type p53. , 1996, Oncogene.

[40]  Y. Pommier,et al.  Initiation of DNA Fragmentation during Apoptosis Induces Phosphorylation of H2AX Histone at Serine 139* , 2000, The Journal of Biological Chemistry.

[41]  L. Dragsted,et al.  Human absorption and excretion of flavonoids after broccoli consumption. , 1997, Cancer letters.

[42]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[43]  E. Rogakou,et al.  Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo , 1999, The Journal of cell biology.

[44]  K. Boehm.  [The flavonoids. I]. , 1959, Arzneimittel-Forschung.

[45]  P. Hollman,et al.  Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man , 1997, FEBS letters.

[46]  M. Yoshizumi,et al.  Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. , 2001, Molecular pharmacology.

[47]  E. Middleton,et al.  Free radical scavenging and antioxidant activity of plant flavonoids. , 1994, Advances in experimental medicine and biology.